Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 14 ... IL-10 Induces Hallmarks of Alternative Activation in Macrophages and Suppresses Antituberculosis Effector Mechanisms without Compromising T Cell Immunity. Journal of Immunology, ...
2009 OCT 5 ... and in-vitro Evaluation of 4-Benzylsulfanylpyridine-2-carbohydrazides as Potential Antituberculosis Agents. Archiv der Pharmazie, 2009;342(7):394-404). For additional ...
2009 OCT 5 ... and when discrimination from bacteria] meningitis is difficult, it is mandatory to start antituberculosis and antibacterial therapy simultaneously or lower the threshold for early...
2009 NOV 1 ... and colleagues published their study in International Journal of STD & AIDS (First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national ...
2009 OCT 5 ... need to identify indicators of treatment success that will allow safe discontinuation of antituberculosis therapy without an increased risk of the reactivation. This will be of great clinical ...
2009 OCT 19 ... in the potent early bactericidal activity of isoniazid during the initial phase of antituberculosis (anti-TB) therapy has been attributed not only to the depletion of logarithmically ...
2009 SEP 28 ... surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening,' have been published. According to recent research from Lucknow, India, ...
2009 AUG 24 ... "Little information exists on the pulmonary pharmacology of antituberculosis drugs. We used population pharmacokinetic modeling and Monte Carlo simulation to ...
2009 NOV 9 ... 32 of whom were HIV-positive, were evaluated at presentation and over 10 weeks of antituberculosis treatment." "Interleukin (IL) 12 and neopterin,Th-1 markers, were both ...
2009 AUG 10 ... (PGTb) was supported by positive PCR assay and histopathological findings. After antituberculosis treatment, nodular lesions were not detected," wrote O. Baylan and colleagues. ...
2009 NOV 16 ... including rifampin (rifampicin) and clofazimine, which are first- and second-line antituberculosis drugs. The efflux pump inhibitors carbonyl cyanide m-chlorophenylhydrazone (CCCP) and ...
2009 OCT 5 ... (PMC) is known to develop after antibiotic treatment, but is rarely associated with antituberculosis (antiTB) agents. We report a 28-year-old woman without underlying diseases developing ...
2009 SEP 21 ... are currently renewed efforts to develop drugs that could shorten the duration of antituberculosis therapy. This is best achieved by optimizing the sterilizing effect," scientists in the ...
2009 NOV 16 ... malachite green and sensitivity to sodium dodecyl sulfate (SDS) detergent and first-line antituberculosis drugs. The lspA mutant has a 10(4)-fold reduction in CFU-forming efficiency on ...
2009 AUG 3 ... sublilus, antifungal activity against Aspergillus niger and Candida albicans and antituberculosis activity against Mycobacterium tuberculosis (H37R(v)).." Mathada and ...
2009 SEP 28 ... antibiotic class in the United States. They have the potential to become first-line antituberculosis therapy, but the effect of fluoroquinolone use on fluoroquinolone resistance in ...
2009 OCT 13 ... and complex septated. The RPT level was measured 12 months after the start of antituberculosis (TB) treatment. Spirometry was performed 6 and 12 months after the start of anti-TB ...
2009 OCT 12 ... skin lesion became smaller after prednisolone therapy and was further improved after antituberculosis drugs were added. Reexamination of the previously biopsied skin tissue disclosed ...
